Navigation Links
Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche
Date:2/9/2010

BOSTON AND LA JOLLA, CA-- Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.

The discovery of the antibodies was first reported by Wayne A. Marasco, MD, PhD, associate professor of medicine at Dana-Farber and Harvard Medical School; Robert Liddington, PhD, professor and director, Infectious and Inflammatory Disease Center at Sanford-Burnham; and Ruben Donis, PhD, chief of the Molecular Virology and Vaccines Branch at the Centers for Disease Control and Prevention, in Nature Structural and Molecular Biology in February 2009.

They demonstrated that the newly identified antibodies attach to the stem region of the viral proteins (hemagglutinin), rather than to the head region, the standard target of current influenza vaccines. Binding to the highly conserved stem region prevents changes in the protein that are necessary for viral entry into the host cell, thereby inhibiting further infection of host cells and the rise of escape mutants. Standard influenza vaccines that consist of an attenuated, or killed, virus typically stimulate antibodies against the protein's head. These vaccines are less effective as the head region is prone to change, leading to the rise of forms of the virus that can evade neutralizing antibodies.

Complete terms of the agreement are not public, but Dana-Farber and Sanford-Burnham will receive license fees and may receive milestone payments and royalties.


'/>"/>
Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
2. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
3. Dana-Farber Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
4. Dana-Farber Cancer Institute Chooses MicroStrategy for Clinical Operations and Clinical Research Reporting Applications
5. InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways
6. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
7. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
8. LifeNet Health Establishes The Skin & Wound Allograft Institute
9. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
10. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
11. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... (PRWEB) May 24, 2013 American Career ... education community, proudly participated in festivities surrounding the 2013 ... The event provided the perfect backdrop to introduce the ... 236 E. 3rd Street, housed in an architectural gem ... , ACC was an active exhibitor throughout the weekend ...
(Date:5/24/2013)... May 24 (HealthDay News) -- About one in five ... teens take up smoking, drinking or illicit drug use, ... bad, say experts at the Substance Abuse and Mental ... parents are actually one of the most influential forces ... "Surveys of teens repeatedly show that parents ...
(Date:5/24/2013)... Paris, France: Routinely measuring fractional flow reserve (FFR) ... diagnosis of chest pain leads to significant changes ... according to results from a study reported at ... wire assessment influence management strategy at coronary angiography ... to assess whether routine assessment of FFR in ...
(Date:5/24/2013)... The news about youth and diabetes keeps getting worse. ... that children who develop Type 2 diabetes are at high ... at a higher rate than people who acquire Type 2 ... 2 diabetes, they seem to be at very high risk ... M.D., professor of pediatric endocrinology in the School of Medicine ...
(Date:5/24/2013)... FL (PRWEB) May 24, 2013 The producers ... May air dates for Charlotte, North Carolina. It is one ... many Fortune 500 companies. The city is populated with more ... organizations which cover residents in both North and South Carolina. ... all things medically-related can tune into WAXN-TV 64 Eyewitness News ...
Breaking Medicine News(10 mins):Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Youth with type 2 diabetes at much higher risk for heart, kidney disease 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2
... recent survey has shown that nearly 25% of people in UK ... of a cream, which has raised alarm among cancer experts, who ... that with blazing August on the cards and a record high ... sun cream to protect the skin. ,The trend is also ...
... to an increased risk of stroke in younger women, ... added to the growing evidence of possible genetic influences ... in the August issue of Human Molecular Genetics, indicate ... depending on the particular genetic variation. ,"This ...
... (IPC) and the US Pharmacopeial Convention (USP) Tuesday ... greater awareness about quality and safety of medicines.// ... technical information on standards for active pharmaceutical ingredients, ... and quality of these products. ...
... A pill that combines chemicals in turmeric and onions has ... new study by Johns Hopkins investigators.// ,The research was ... University School of Medicine and Dr. Marcia Cruz-Correa of Johns ... , ,Giardiello says, “We believe this is the ...
... the efforts made by it to encourage mothers to breastfeed ... wanted to give their babies' breast milk. ,The ... the rate of breastfeeding in Hong Kong increased to 12 ... are for exclusive breastfeeding. The numbers for mothers who ever ...
... researchers have found that mutation causes receptors to miss signals ... when not to eat //. Genetic obesity accounts for ... has long been associated with mutation in melanocortin-4 receptor, a ... finding will help scientist to move a step closer to ...
Cached Medicine News:Health News:Stroke Risk Higher with Gene Variations 2Health News:Scientist Move A Step Closer To Treating Genetic Obesity 2Health News:Scientist Move A Step Closer To Treating Genetic Obesity 3
(Date:5/23/2013)... May 23, 2013   Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
(Date:5/23/2013)...  Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) ... development and commercialization of novel bile acid therapeutics to ... today announced that Mark Pruzanski , ... the Deutsche Bank Securities 38th Annual Health Care Conference ... 29, 2013 at 4:10 p.m. ET. About ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Angel Medical Systems announced today that it has received ... of The AngelMed Guardian System in Europe.  The Guardian ... detect coronary occlusion from thrombotic events such as plaque ...  The System is comprised of an internal implantable device ...
... Abbott,s Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results -- ABBOTT PARK, Ill., Sept. ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Angel Medical Systems Receives CE Mark Approval for the AngelMed Guardian, an Implantable Device Designed to Provide Early Warning of a Heart Attack 2Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 2Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 3Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 4Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 5Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 6Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 7Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 8Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results 9
... ACUSON Cypress cardiovascular system ... worlds first portable, high-performance transesophageal ... highly miniaturized, all-digital, phased array ... studies and outstanding images, even ...
... Hybrid Imaging in ... offer unmatched imaging solutions in ... high quality coronary CT angiography ... and visibility. Symbia TruePoint ...
... MIYABI supports interventional cardioangiography procedures with MR ... a cardioangiography system., Utilize your angio and ... with our integrated suite. Because the systems ... enjoy diagnosis and follow-up in one room, ...
MAGNETOM Avanto, the worlds first Tim MRI system, provides unsurpassed image quality, enhanced productivity, and greater patient comfort....
Medicine Products: